Citadel Advisors
TVGNW icon

Citadel Advisors’s Tevogen Inc. Warrant TVGNW Stock Holding History

Citadel Advisors’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,891
Closed -$716 – 15561
2023
Q4 		$716 Sell
17,891
-781
-4% -$32 ﹤0.01% 13956
2023
Q3 		$1.23K Buy
18,672
+3,314
+22% +$177 ﹤0.01% 13895
2023
Q2 		$633 Sell
15,358
-4,212
-22% -$227 ﹤0.01% 14073
2023
Q1 		$984 Sell
19,570
-4,900
-20% -$271 ﹤0.01% 14388
2022
Q4 		$184 Buy
+24,470
New +$712 ﹤0.01% 14735

Other funds holding TVGNW

FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Citadel Advisors's TVGNW Position: Q1 2024 in Review

Citadel Advisors sold out of Tevogen Inc. Warrant (TVGNW) in Q1 2024, closing a stake of 17,891 shares — an estimated $716 sold.

Citadel Advisors first reported a position in TVGNW in Q4 2022 and held it in 5 quarters. The position peaked at $1.23K in Q3 2023. 41 funds tracked by Wall St. Rank hold TVGNW as of Q1 2024.

  • Citadel Advisors reported no remaining Tevogen Inc. Warrant position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 17,891 Tevogen Inc. Warrant shares in Q1 2024, an estimated $716.
  • Citadel Advisors first reported a position in Tevogen Inc. Warrant in Q4 2022 and held it in 5 quarters.
  • Citadel Advisors's Tevogen Inc. Warrant position peaked at $1.23K in Q3 2023.
  • 41 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.